Avenue Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$10,377,000 over the previous period. Total operating expenses were $14,540,000.
Profit Margin
| 2015 | 0 | -5.22M | |
|---|---|---|---|
| 2016 | 0 | -3.17M | |
| 2017 | 0 | -12.25M | |
| 2018 | 0 | -21.28M | |
| 2019 | 0 | -25.55M | |
| 2020 | 0 | -5.08M | |
| 2021 | 0 | -3.72M | |
| 2022 | 0 | 2.04M | |
| 2023 | 0 | -10.37M |
ATXI Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 10.36M | 2.69M | 1.25M | 2.86M | 23.19M | 17.69M | 7.80M | 1.38M | 4.00M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -76.54K |
Total operating expenses | 14.54M | 8.04M | 3.73M | 5.21M | 26.26M | 21.81M | 11.42M | 2.37M | 4.84M |
Operating income | -14.54M | -8.04M | -3.73M | -5.21M | -26.26M | -21.81M | -11.42M | -2.37M | -4.84M |
Other income (expenses), net | 4.05M | 4.44M | 7K | 62K | 357K | 268K | -837K | -188K | -383K |
Income before tax | -10.48M | -3.60M | -3.73M | -5.15M | -25.90M | -21.54M | -12.25M | -3.17M | -5.22M |
Income tax expense | 0 | -5.65M | -7K | -62K | -357K | -268K | 287K | 0 | -5.28M |
Net income | -10.37M | 2.04M | -3.72M | -5.08M | -25.55M | -21.28M | -12.25M | -3.17M | -5.22M |
Earnings per share | |||||||||
Basic EPS | -73.6 | 0.94 | -3.29 | -4.62 | -24.38 | -31.17 | -27.71 | -5.39 | -9.4 |
Diluted EPS | -73.48 | 0.94 | -3.29 | -4.62 | -24.38 | -31.17 | -27.71 | -5.39 | -9.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |